MediPharm Labs Initiates Clinical Trial for Use of Cannabis to Treat Chronic Kidney Disease Patients and Improve Quality of Life
MediPharm Labs Corp., (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) is a global leader in […]
MediPharm Labs Corp., (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) is a global leader in […]
Goodness Growth Holdings, Inc., (CSE: GDNS; OTCQX: GDNSF) a cannabis company involved in cultivating, […]
Khiron Life Sciences Corp., (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMZC), a vertically-integrated, global operator […]
Dr. Reddy’s Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, a leading […]
Tilray Brands, Inc. (NASDAQ: TLRY) TSX: TLRY), a leading Canadian cannabis company, incorporated in […]
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), the cannabis company that has mainly focused […]
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), a vertically-integrated and top-performing cannabis company in […]
Pfizer Inc. (NYSE: PFE), the pharmaceutical and biotechnology giant, is entering the cannabis space […]
MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF), a leading cannabis retailer with operations across […]
Akanda Corp., a company focused on providing ethically-sourced medical cannabis products for patients, announced […]
The Dank Investor is an industry leading cannabis financial services company providing breaking market news, analysis and leading insights about cannabis stocks for investors to grow their portfolios and minimize risk. Markets include NASDAQ, NYSE, OTC and other markets. Additionally, the company provides business services to companies in the cannabis sector through comprehensive corporate communication and marketing solutions.
The Dank Investment Community encompasses an engaged social media audience of over 50,000 who leverage our content to stay informed as investors.
We seek Safe Harbor.